ORAL SODIUM BICARBONATE SUPPLEMENTATION IN PATIENTS WITH CHRONIC METABOLIC ACIDOSIS AND CHRONIC KIDNEY DISEASE - Oral SoBic supplementation in patients with CKD

Medizinsiche Universität Wien, Klinik für Innere Medizin III, Abteilung für Nephrologie und Dialyse0 个研究点目标入组 200 人开始时间: 2012年6月11日最近更新: 2012年8月7日

试验速览

暂无简介。

•Age =18 years.
•Renal function (measured by eGFR-MDRD) between 60 and 15mL/min/ 1.73m2.
•Venous serum HCO3- of <21mml/L on two consecutive measurements, at least one day apart.
•Stable condition.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 200
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 200

•Malignant disease or <5years after a successfully treated malignant disease (except dermal malignancies and carcinoma in situ of the cervix declared to be cured).
•Morbid obesity (BMI >40 kg/m2).
•Chronic sepsis (C reactive protein > 10 mg/dL).
•Immunosuppressive therapy of any kind.
•Poorly controlled blood pressure (>150/90mmHg despite the use of 4 agents)
•Overt congestive heart failure.
•Known peanut and/or soy allergy.

发起方

Medizinsiche Universität Wien, Klinik für Innere Medizin III, Abteilung für Nephrologie und Dialyse